HoT, LaneDP. The guardian of genome editing. CRISPR J, 2018; 1:250–260. DOI: 10.1089/crispr.2018.29021.dal.
2.
HaapaniemiE, BotlaS, PerssonJ, et al.CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. Nat Med, 2018; 24:927–930. DOI: 10.1038/s41591-018-0049-z.
3.
IhryRJ, WorringerKA, SalickMR, et al.p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med, 2018; 24:939–946. DOI: 10.1038/s41591-018-0050-6.
4.
RoganEM, BryanTM, HukkuB, et al.Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li–Fraumeni Syndrome fibroblasts. Mol Cell Biol, 1995; 15:4745–4753.
5.
TsukadaT. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene, 1993; 8:3313–3322.
6.
HarveyDJ, LevineAJ. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev, 1991; 5:2375–2385.
7.
SherleyJL, StadlerPB, JohnsonDR. Expression of the wild-type p53 antioncogene induces guanine nucleotide-dependent stem cell division kinetics. Proc Natl Acad Sci U S A, 1995; 92:136–140.
8.
RambhatlaL, BohnSA, StadlerPB, et al.Cellular senescence: ex vivo p53-dependent asymmetric cell kinetics. J Biomed Biotech, 2001; 1:27–36. DOI: 10.1155/S1110724301000079.
9.
ParéJF, SherleyJL. Biological principles for ex vivo adult stem cell expansion. In: SchattenG, ed. Current Topics in Developmental Biology. Vol. 73. San Diego, CA: Elsevier, 2006:141–171.
10.
SherleyJL. New cancer diagnostics and therapeutics from a 9th “hallmark of cancer”: symmetric self-renewal by mutated distributed stem cells. Expert Rev Mol Diagn, 2013; 13:797–810. DOI: 10.1586/14737159.2013.845087.
11.
LeeHS, CraneGG, MerokJR, et al.Clonal expansion of adult rat hepatic stem cell lines by suppression of asymmetric cell kinetics (SACK). Biotech Bioeng, 2003; 83:760–771. DOI: 10.1002/bit.10727.
